Tetraspanins: Architects of Viral Entry and Exit Platforms.

Animals Cell Membrane / metabolism Humans Membrane Fusion / physiology Tetraspanins / metabolism Virus Diseases / metabolism Virus Internalization
coronavirus membrane fusion tetraspanin virus entry

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 03 2019
Historique:
received: 21 11 2018
accepted: 11 12 2018
pubmed: 21 12 2018
medline: 20 11 2019
entrez: 21 12 2018
Statut: epublish

Résumé

Host factors render cells susceptible to viral infection. One family of susceptibility factors, the tetraspanin proteins, facilitate enveloped virus entry by promoting virus-cell membrane fusion. They also facilitate viral egress from infected cells. In this Gem, we discuss recent insights into how tetraspanins assemble viral entry and exit platforms on cell membranes, and we speculate that tetraspanins contribute to nonviral membrane fusions by similar mechanisms.

Identifiants

DOI: 10.1128/JVI.01429-17 PMID: 30567993 PMC: PMC6401424
pubmed: 30567993
pii: JVI.01429-17
doi: 10.1128/JVI.01429-17
pmc: PMC6401424
pii:
doi:

Substances chimiques

Tetraspanins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

FEBS Lett. 2002 Apr 10;516(1-3):139-44
pubmed: 11959120
PLoS Pathog. 2017 Jul 31;13(7):e1006546
pubmed: 28759649
J Virol. 2016 Jun 24;90(14):6430-42
pubmed: 27147745
Virol J. 2010 Jul 14;7:156
pubmed: 20630051
PLoS Pathog. 2013;9(10):e1003701
pubmed: 24130495
Exp Cell Res. 2006 Dec 10;312(20):3969-80
pubmed: 17010968
J Cell Biol. 2008 Nov 3;183(3):527-42
pubmed: 18955551
Microbiol Mol Biol Rev. 2005 Dec;69(4):635-64
pubmed: 16339739
PLoS One. 2008 Oct 02;3(10):e3313
pubmed: 18836553
J Virol. 2013 Mar;87(6):3435-46
pubmed: 23302890
Biochem J. 2009 May 13;420(2):133-54
pubmed: 19426143
J Cell Biol. 1999 Aug 23;146(4):893-904
pubmed: 10459022
Trends Biochem Sci. 2003 Feb;28(2):106-12
pubmed: 12575999
AIDS Res Hum Retroviruses. 1993 Nov;9(11):1157-65
pubmed: 8312057
Viruses. 2014 Mar 07;6(3):1078-90
pubmed: 24608085
Biochem J. 1999 May 15;340 ( Pt 1):103-11
pubmed: 10229664
Nat Rev Mol Cell Biol. 2005 Oct;6(10):801-11
pubmed: 16314869
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
PLoS Pathog. 2011 Oct;7(10):e1002337
pubmed: 22046135
J Virol. 2008 Jan;82(2):1021-33
pubmed: 17989173
PLoS One. 2014 Jan 23;9(1):e86671
pubmed: 24466195
Virus Res. 2015 Apr 16;202:120-34
pubmed: 25445340
Int J Biochem Cell Biol. 2011 Jan;43(1):106-19
pubmed: 20937409
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6
pubmed: 19321428
J Virol. 2005 Sep;79(17):10839-51
pubmed: 16103137
Nature. 2013 Mar 14;495(7440):251-4
pubmed: 23486063
J Bone Miner Res. 2006 Jun;21(6):965-76
pubmed: 16753027
J Biol Chem. 2003 Oct 24;278(43):41624-30
pubmed: 12913001
J Virol. 2011 May;85(9):4122-34
pubmed: 21325420
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81
pubmed: 16081529
Proteomics. 2006 Dec;6(24):6447-54
pubmed: 17109380
Hepatology. 2013 Feb;57(2):461-9
pubmed: 22996292
Hepatology. 2010 Apr;51(4):1144-57
pubmed: 20069648
J Cell Biol. 2006 Jun 5;173(5):795-807
pubmed: 16735575
Mol Biol Cell. 2002 Mar;13(3):767-81
pubmed: 11907260
PLoS Pathog. 2008 Jun 06;4(6):e1000085
pubmed: 18535660
PLoS Pathog. 2014 Apr 03;10(4):e1004048
pubmed: 24699674
PLoS Pathog. 2013;9(12):e1003835
pubmed: 24367265
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):E3119-E3128
pubmed: 28348219
Development. 2013 Nov;140(22):4471-9
pubmed: 24194470
Mol Biol Cell. 1998 Oct;9(10):2751-65
pubmed: 9763442
Genomics. 2005 Dec;86(6):674-84
pubmed: 16242907
Placenta. 2015 Apr;36 Suppl 1:S35-42
pubmed: 25564303
J Virol. 2016 Dec 16;91(1):
pubmed: 27733646
J Biol Chem. 2010 Jul 2;285(27):21092-102
pubmed: 20375010
Antiviral Res. 2015 Apr;116:76-84
pubmed: 25666761
Biochem Biophys Res Commun. 2003 Apr 25;304(1):107-12
pubmed: 12705892
J Virol. 2009 Aug;83(15):7467-74
pubmed: 19458002
J Virol. 2009 Sep;83(17):8744-58
pubmed: 19553314
J Virol. 2013 Dec;87(23):12552-61
pubmed: 24027332
Cell Mol Life Sci. 2001 Aug;58(9):1189-205
pubmed: 11577978
Biochem Biophys Res Commun. 2011 Jun 10;409(3):378-84
pubmed: 21600883
Cell. 2010 Sep 17;142(6):902-13
pubmed: 20850012
J Virol. 2016 Apr 14;90(9):4289-97
pubmed: 26865714
Biochem Biophys Res Commun. 2011 Dec 2;415(4):619-26
pubmed: 22079629
J Virol. 2004 Jun;78(11):6048-54
pubmed: 15141003
J Virol. 2014 May;88(9):4943-52
pubmed: 24554652
Virology. 2018 Apr;517:9-15
pubmed: 29217279
Nat Genet. 2000 Mar;24(3):279-82
pubmed: 10700183
Proteomics. 2006 Mar;6(5):1437-49
pubmed: 16404722
Int J Exp Pathol. 2000 Oct;81(5):291-304
pubmed: 11168677
J Virol. 2007 Aug;81(15):7873-84
pubmed: 17522207
Cell Microbiol. 2017 May;19(5):
pubmed: 27930836
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12921-6
pubmed: 18728192
J Immunol. 2006 Oct 15;177(8):5129-37
pubmed: 17015697
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12262-12267
pubmed: 27791014
Cell Host Microbe. 2017 Nov 8;22(5):688-696.e5
pubmed: 29120745
J Biol Chem. 1989 Jul 25;264(21):12289-93
pubmed: 2745443
Science. 1998 Oct 30;282(5390):938-41
pubmed: 9794763
Curr Opin Genet Dev. 2015 Jun;32:162-70
pubmed: 25989064
J Virol. 2015 Jun;89(11):6093-104
pubmed: 25833045
Cell. 2016 Nov 3;167(4):1041-1051.e11
pubmed: 27881302
J Virol. 2009 Nov;83(21):11133-41
pubmed: 19706706

Auteurs

Michael P Hantak (MP)

Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.

Enya Qing (E)

Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.

James T Earnest (JT)

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

Tom Gallagher (T)

Department of Microbiology and Immunology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA tgallag@luc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Tetraspanins: Architects of Viral Entry and...
questionsmedicales.fr › Cellules › Structures cellulaires › Membrane cellulaire › Tetraspanins: Architects of Viral Entry and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Tetraspanins: Architects of Viral Entry and...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Fusion membranaire › Tetraspanins: Architects of Viral Entry and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Tétraspanines › Tetraspanins: Architects of Viral Entry and...
questionsmedicales.fr › Infection › Maladies virales › Tetraspanins: Architects of Viral Entry and...
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Pénétration virale › Tetraspanins: Architects of Viral Entry and...